Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v6-EN
Language French English
Date Updated 2022-10-17 2022-07-06
Drug Identification Number 02411393 02411393
Brand name ILEVRO ILEVRO
Common or Proper name ILEVRO 0.3% SUSP. 3ML ILEVRO 0.3% SUSP. 3ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients NEPAFENAC NEPAFENAC
Strength(s) 0.3% 0.3%
Dosage form(s) SUSPENSION SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC OPHTHALMIC OPHTHALMIC
Packaging size 3ML 3ML
ATC code S01BC S01BC
ATC description ANTIINFLAMMATORY AGENTS ANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-07-05 2022-07-05
Actual start date 2022-07-05
Estimated end date 2022-10-14 2022-07-15
Actual end date 2022-10-14
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments